ImmuCell Corporation
ICCC | NASDAQ
$10.26
-$0.06 (-0.58%)
At close: Oct 30, 2026, 4:00 PM ET
$10.26
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | 27.64M | 26.49M | 17.47M | 18.57M | 19.24M | 15.34M |
Cost of Revenue | 16.2M | 18.55M | 13.08M | 10.92M | 10.59M | 8.48M |
Gross Profit | 11.45M | 7.94M | 4.4M | 7.65M | 8.66M | 6.86M |
Operating Income | 1.65M | -1.64M | -5.75M | -2.3M | 257.39K | -1.38M |
Interest Income | 158.71K | 77.7K | 96.57K | 153.1K | 18.81K | 27.44K |
Pretax Income | -1.03M | -2.15M | -5.77M | -2.49M | -69.13K | -1.03M |
Net Income | -1.04M | -2.16M | -5.77M | -2.49M | -78.29K | -1.02M |
Selling & General & Admin | 6.75M | 5.68M | 5.22M | 5.45M | 4.23M | 3.89M |
Research & Development | 3.04M | 3.9M | 4.39M | 4.49M | 4.17M | 4.35M |
Other Expenses | n/a | n/a | 527K | n/a | n/a | n/a |
Operating Expenses | 9.8M | 9.58M | 10.14M | 9.95M | 8.4M | 8.24M |
Interest Expense | 439.04K | 568.73K | 452.98K | 348.54K | 314.36K | 412.69K |
Selling & Marketing Expenses | 3.55M | 3.47M | 3.09M | 3.19M | 2.5M | 2.17M |
Cost & Expenses | 25.99M | 28.13M | 23.22M | 20.87M | 18.99M | 16.72M |
Income Tax Expense | 11.57K | 10.06K | 4.63K | 8K | 9.17K | -10K |
Shares Outstanding (Basic) | 9.03M | 8.17M | 7.7M | 7.75M | 7.59M | 7.21M |
Shares Outstanding (Diluted) | 9.03M | 8.17M | 7.75M | 7.75M | 7.59M | 7.21M |
EPS (Basic) | -0.12 | -0.26 | -0.75 | -0.32 | -0.01 | -0.14 |
EPS (Diluted) | -0.12 | -0.26 | -0.75 | -0.32 | -0.01 | -0.14 |
EBITDA | 2.14M | 1.07M | -2.5M | 349.99K | 2.7M | 1.65M |
EBIT | -589.42K | -1.62M | -5.22M | -2.14M | 237.39K | -714.35K |
Depreciation & Amortization | 2.73M | 2.69M | 2.72M | 2.49M | 2.46M | 2.36M |
Add to Watchlist
Select watchlists to add or remove ICCC